| |
| | Untitled Document |
 | | Mean acute reductions in total, LDL, and Lp(a) cholesterol levels were 70 percent, 81 percent, and 68 percent, respectively, in homozygotes and 61 percent, 76 percent, and 65 percent, respectively, in heterozygotes. |
 | | There was a 44 percent reduction in cardiovascular events during the 5 years the patients received LDL-apheresis compared with the 5-year period prior to LDL apheresis (3.5 events per 1,000 patient-months of treatment compared with 6.3 events per 1,000 patient-months before LDL-apheresis therapy). |
 | | Two patients are continuing to receive regular biweekly LDL apheresis treatments at the Clinical Center, while a third patient, a child, receives biweekly plasma exchange until his blood volume becomes large enough to tolerate the extracorporeal volume of the LDL apheresis device. |
| www.cc.nih.gov /ccc/annual_report/rpt992/Z01CL-02062-09.htm (442 words) |
|